These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 9463367)

  • 1. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.
    Simonin F; Valverde O; Smadja C; Slowe S; Kitchen I; Dierich A; Le Meur M; Roques BP; Maldonado R; Kieffer BL
    EMBO J; 1998 Feb; 17(4):886-97. PubMed ID: 9463367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kappa opioid receptor is associated with the perception of visceral pain.
    Black D; Trevethick M
    Gut; 1998 Sep; 43(3):312-3. PubMed ID: 9863470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.
    Valverde O; Ledent C; Beslot F; Parmentier M; Roques BP
    Eur J Neurosci; 2000 Feb; 12(2):533-9. PubMed ID: 10712632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
    Sounvoravong S; Takahashi M; Nakashima MN; Nakashima K
    J Pharmacol Sci; 2004 Mar; 94(3):305-12. PubMed ID: 15037816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
    Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
    Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.
    Huang P; Chen C; Cao D; Huang M; Liu-Chen LY
    Neuropharmacology; 2022 Jan; 202():108860. PubMed ID: 34736959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
    Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
    Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.
    Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY
    Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
    Bileviciute-Ljungar I; Spetea M
    Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
    Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T
    Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice.
    Shin EJ; Jang CG; Bing G; Park DH; Oh CH; Koo KH; Oh KW; Yamada K; Nabeshima T; Kim HC
    Drug Alcohol Depend; 2009 Sep; 104(1-2):175-84. PubMed ID: 19559544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.
    McLaughlin JP; Land BB; Li S; Pintar JE; Chavkin C
    Neuropsychopharmacology; 2006 Apr; 31(4):787-94. PubMed ID: 16123754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
    Cui CL; Wu LZ; Han JS
    Neurosci Lett; 2000 Dec; 295(1-2):45-8. PubMed ID: 11078933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.
    King MA; Bradshaw S; Chang AH; Pintar JE; Pasternak GW
    J Neurosci; 2001 Oct; 21(19):7788-92. PubMed ID: 11567069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.